# Trending Content OS — Daily Run
**Run date:** 2026-09-02 | **Niche:** Health & Wellness

---

## 1. Preflight Summary

| Check | Status |
|---|---|
| All 7 configs + CLAUDE.md sections loaded | ✅ |
| `site_niche` / `target_audience` set | ✅ |
| `site_url` | ⚠️ Not configured — self-check skipped, competitor-list fallback used (`configs/competitor_list.yaml`) |
| SerpAPI connected | ✅ |
| Google Trends | ✅ Available via injected pre-fetch (`search_velocity_source: google_trends`) |
| Google News Radar | ✅ Injected (144 unique / 12 queries) |
| Deferred topics (`data/deferred_topics.yaml`) | No overdue `recheck_on` entries found |
| Run history recurrence check | Recall stories, GLP-1 coverage, and "mental health awareness month" content have appeared in 3+ of the last 5 logged runs → flagged recurring, staleness risk noted below |

`next_action: run_signal_listener` — proceeded with full pipeline.

---

## 2. Google News Radar Coverage Summary

**Cluster: FDA/food recall surge** (10+ headlines: [FDA.gov sprouts outbreak](https://www.fda.gov/food/outbreaks-foodborne-illness/outbreak-investigation-shiga-toxin-producing-e-coli-salmonella-sprouts-august-2026), [Healthline](https://www.healthline.com/health-news/fda-recalls-iv-saline-fluids-fiberglass-stainless-steel-contaminants), [health.com tofu recall](https://www.health.com/tofu-recall-august-2026-12073618), [The Healthy olive oil](https://www.thehealthy.com/news/olive-oil-recall-august-2026/), [People.com rice recall](https://people.com/fda-issues-update-lundberg-family-farms-white-rice-jasmine-recall-13-states-12072609), [New Republic](https://newrepublic.com/post/214946/food-recall-fda-list-august-skyrocket)) — **Retained (update)**. Individual recalls (Medtronic, Baxter, thyroid, herbal supplements) were already covered this week; tofu, olive oil, rice, and the sprouts outbreak are net-new developments that justify an aggregate "recall surge" update.

**Cluster: Clinical trial access barriers** ([Inquirer](https://www.inquirer.com/health/clinical-trial-how-to-join-what-to-know-20260826.html), [CancerHealth](https://www.cancerhealth.com/article/costs-geographic-barriers-impact-cancer-clinical-trial-participation), [CancerNetwork](https://www.cancernetwork.com/shorts/how-can-health-networks-bring-clinical-trials-directly-to-patients-), [The Scientist](https://www.the-scientist.com/cancer-clinical-trials-are-excluding-the-patients-they-are-meant-to-help-74951)) — **Retained (new)**. Four independent outlets converging on the same structural story with no Google Trends footprint yet — classic Discover/news-led opportunity.

**Cluster: New treatment/trial announcements** — [pancreatic cancer FDA approval (daraxonrasib)](https://news.med.miami.edu/fda-approves-daraxonrasib-pancreatic-cancer-treatment/), [Moderna Ebola vaccine Phase 1](https://abcnews.com/Health/moderna-begins-phase-1-clinical-trial-ebola-vaccine/story?id=135365177), [ibogaine trial at Barrow/ASU](https://news.asu.edu/20260831-health-and-medicine-barrow-asu-embark-one-first-clinical-trials-ibogaine-us) — **Retained (new, each routed through 02b)**.

**Cluster: Single-study research** — [calcium testing limited value (WaPo)](https://www.washingtonpost.com/wellness/2026/08/28/calcium-testing-heart-health-may-have-limited-value-many-new-study-suggests/), [flu vaccine immune cells (Rochester)](https://www.urmc.rochester.edu/news/story/hidden-immune-cells-in-the-lung-could-lead-to-better-flu-vaccines), [food insecurity/dementia link (News-Medical)](https://www.news-medical.net/news/20260827/Study-links-later-life-food-insecurity-to-elevated-dementia-risk.aspx) — **Retained (new)**. [Low-carb/liver study](https://medicine.washu.edu/news/low-carb-diet-delivers-added-liver-benefits-beyond-weight-loss/) and [GLP-1 psychiatric safety study](https://medicalxpress.com/news/2026-08-glp-1s-major-psychiatric.html) — **Rejected: existing**, already covered 2026-08-27/08-28.

**Cluster: Healthcare business/institutional news** — OpenAI-EHR integration, [employer health cost spike (NYT)](https://www.nytimes.com/2026/09/02/business/health-insurance-increases.html), Corewell $1.7B investment, Sanford/North Memorial merger, UVA Lynchburg expansion, Sword Health–Headspace acquisition, $50B rural health transparency — **Rejected: off-category** (pure business/M&A/local expansion, no direct patient-health data angle).

**Cluster: Wellness marketing/PR** — Kroger wellness tours, CVS/LOVB partnership, BCG activewear-wellness spending report, campus/senior wellness events — **Rejected: off-category/brand-safety** (marketing and events, not evidence-based content).

**Cluster: Research funding politics** — [UW funding cuts under Trump admin](https://www.kuow.org/science/2026-08-26/uw-struggles-to-see-medical-research-through-as-trump-administration-guts-funding) — **Rejected: off-category** (political healthcare framing, `allow_politics: false`).

**Cluster: Local/niche/single-source** — Florida DOH Miami-Dade water advisory, Fresenius-sponsored hemodiafiltration study, Penn proton therapy trial launch, Data4Life Dubai rWGS, Clinical Leader industry commentary, WHO Oct. 9 webinar — **Monitored/Rejected** (too local, manufacturer-sponsored, single-source, or too far out — see Rejected Log).

**Cluster: Mental health awareness month / suicide prevention** (Trends: mental health 95, delta +9; multiple "is September mental health month" queries) — **Monitored, not retained**. Already covered 2026-09-01; recurring 3rd+ appearance in Trends this week — flagged staleness risk, no new development to justify an update today.

---

## 3. Signal Summary

```yaml
signal_summary:
  run_started_at: "2026-09-02T13:00:00Z"
  run_completed_at: "2026-09-02T13:40:00Z"
  total_signals_reviewed: 144
  total_signals_retained: 9
  total_rejected: 24
  google_trends_available: true
  search_velocity_source: "google_trends"
  rejection_breakdown:
    off_category: 14
    brand_safety: 3
    duplicate: 3
    weak_signal: 3
    unverified_claim: 0
    other: 1
  highest_priority_topic: "FDA food recall surge (tofu, olive oil, rice, sprouts)"
  strongest_signal_source: "FDA.gov + Healthline/health.com/People convergence"
  tools_unavailable: []
  notes: >
    Food safety search velocity (+20 7d-delta) and heavy recall news volume converge strongly.
    Mental-health-month and GLP-1/recall single-item stories are recurring 3+ runs — staleness risk;
    suppressed today absent new development. site_url not configured — self-check skipped,
    competitor-list fallback used for SERP-gap context.
```

---

## 4. Skill 02b — Health Claim Verification Gate Routing Summary

| Topic | Risk Type | Primary Source | Gate Result | Confidence Cap |
|---|---|---|---|---|
| FDA food recall surge | recall | FDA.gov outbreak page + FDA notices via Healthline/health.com/People | **Pass** | — |
| Pancreatic cancer approval (daraxonrasib) | drug_or_treatment_claim | FDA approval action, institutional release | **Pass** | Medium (single outlet so far) |
| Moderna Ebola vaccine trial | clinical_trial | Moderna/ClinicalTrials.gov via ABC News | **Pass** | Medium |
| Ibogaine trial (Barrow/ASU) | clinical_trial | ASU News institutional release | **Pass** | Medium |
| Calcium testing study | study_or_research | WaPo (tier-1), names study | **Pass** | Medium |
| Flu vaccine immune-cell discovery | study_or_research | Univ. of Rochester institutional release | **Pass** | Medium |
| Food insecurity/dementia link | study_or_research | News-Medical (secondary) | **Pass** | Medium — verify journal/DOI before publishing |
| Medical marijuana & missing work | study_or_research | GPB citing UGA study | **Pass** | Medium — policy-adjacent, borderline category fit |

No candidates rejected or routed to Monitor at 02b this run.

---

## 5. Final Editorial Priority Board

| Priority | Topic | Publish Timing | Trend | Opp. | Discover | Urgency | Confidence |
|---|---|---|---|---|---|---|---|
| **P1** | FDA food recall surge (tofu/olive oil/rice/sprouts) | immediate | 82 | 78 | 4 | today | high |
| **P2** | Clinical trial access barriers | short_term | 65 | 72 | 4 | this_week | high |
| **P2** | Pancreatic cancer FDA approval (daraxonrasib) | short_term | 70 | 68 | 4 | today | medium |
| **P2** | Calcium testing — limited value for heart health | short_term | 68 | 70 | 4 | this_week | medium |
| **P3** | Moderna Ebola vaccine Phase 1 trial | scheduled | 60 | 62 | 3 | this_week | medium |
| **P3** | Ibogaine — first-in-nation clinical trial | scheduled | 58 | 64 | 4 | this_week | medium |
| **P3** | Flu vaccine — hidden lung immune cells | scheduled | 55 | 60 | 3 | this_week | medium |
| **P3** | Food insecurity linked to dementia risk | scheduled | 56 | 61 | 3 | this_week | medium |
| **P5** | Medical marijuana & workplace absence | monitor | 48 | 52 | 2 | evergreen | low-medium |

---

## 6. Editorial Briefs

### P1 — FDA Food Recall Surge
```yaml
priority_level: P1
publish_timing: immediate
topic: "FDA food recall surge continues: tofu, olive oil, and rice join record 2026 recall total"
primary_entity: "FDA"
signal_type: recall
allowed_category: "FDA and CDC regulatory updates"
trend_strength_score: 82
opportunity_score: 78
discover_score: 4
urgency: today
confidence: high
content_status: update
source_count: 6
recommended_angle: "Data-driven explainer connecting today's specific new recalls (tofu/ink, olive oil/unapproved ingredient, white rice/foreign material, sprouts E. coli-Salmonella) to the broader 2026 recall-volume trend — practical home food-safety guidance layered on top."
why_now: "New development since 08-28 aggregate coverage: four distinct new recalls/outbreak investigations in the last 5 days, each with an active FDA notice."
primary_headline: "FDA Recalls Are Piling Up Again This Week — Here's What's Actually Contaminated and What to Do"
next_steps: "Assign to food-safety writer; pull FDA.gov recall/outbreak pages directly for each item; distinguish confirmed recalls from ongoing outbreak investigation (sprouts)."
notes: "⚠️ Integrity note: don't imply a single systemic cause across unrelated recalls (different manufacturers/contaminants) without data support."
sources:
  - {publisher: "FDA.gov", url: "https://www.fda.gov/food/outbreaks-foodborne-illness/outbreak-investigation-shiga-toxin-producing-e-coli-salmonella-sprouts-august-2026", tier: 1}
  - {publisher: "Health.com", url: "https://www.health.com/tofu-recall-august-2026-12073618", tier: 2}
  - {publisher: "The Healthy", url: "https://www.thehealthy.com/news/olive-oil-recall-august-2026/", tier: 2}
  - {publisher: "People.com", url: "https://people.com/fda-issues-update-lundberg-family-farms-white-rice-jasmine-recall-13-states-12072609", tier: 2}
```

### P2 — Clinical Trial Access Barriers
```yaml
priority_level: P2
publish_timing: short_term
topic: "Why most cancer patients still can't access clinical trials"
primary_entity: "clinical trial access"
signal_type: audience_pain_point
allowed_category: "medical research and clinical trials"
trend_strength_score: 65
opportunity_score: 72
discover_score: 4
urgency: this_week
confidence: high
content_status: new
source_count: 4
recommended_angle: "Explainer: cost + geography as the real barrier to trial enrollment, using named researcher commentary from the-scientist.com and CancerHealth; give readers a practical 'how to find a trial near you' framework."
why_now: "Four independent outlets converged on this story in the same week with no prior site coverage — clear SERP gap between trade-press depth and consumer-facing explainers."
primary_headline: "The Hidden Reason Most Cancer Patients Never Make It Into a Clinical Trial"
next_steps: "Assign to health-policy writer; pull direct quotes from The Scientist and CancerHealth sources; cross-check ClinicalTrials.gov enrollment data if available."
notes: "No 02b trigger — systemic access story, not a specific treatment claim."
sources:
  - {publisher: "The Scientist", url: "https://www.the-scientist.com/cancer-clinical-trials-are-excluding-the-patients-they-are-meant-to-help-74951", tier: 2}
  - {publisher: "CancerHealth", url: "https://www.cancerhealth.com/article/costs-geographic-barriers-impact-cancer-clinical-trial-participation", tier: 2}
  - {publisher: "The Inquirer", url: "https://www.inquirer.com/health/clinical-trial-how-to-join-what-to-know-20260826.html", tier: 2}
```

### P2 — Pancreatic Cancer FDA Approval (Daraxonrasib)
```yaml
priority_level: P2
publish_timing: short_term
topic: "FDA approves daraxonrasib for pancreatic cancer"
primary_entity: "daraxonrasib"
signal_type: drug_or_treatment_claim
allowed_category: "medical research and clinical trials"
trend_strength_score: 70
opportunity_score: 68
discover_score: 4
urgency: today
confidence: medium
content_status: new
source_count: 2
recommended_angle: "What this approval actually means for patients — trial population, survival data, and realistic expectations, not a 'breakthrough cure' framing."
why_now: "Fresh FDA approval, first coverage of this specific drug on our site."
primary_headline: "FDA Approves New Pancreatic Cancer Drug — Here's What the Data Actually Shows"
next_steps: "Confirm FDA approval record directly via FDA.gov before publishing; source oncologist commentary per Skill 08 sourcing rules."
notes: "⚠️ Integrity note: approval ≠ cure — cite trial phase/population and magnitude of survival benefit; avoid overpromising language."
sources:
  - {publisher: "University of Miami", url: "https://news.med.miami.edu/fda-approves-daraxonrasib-pancreatic-cancer-treatment/", tier: 2}
```

### P2 — Calcium Testing for Heart Health
```yaml
priority_level: P2
publish_timing: short_term
topic: "Calcium testing for heart health may have limited value for many, study finds"
primary_entity: "coronary calcium scan"
signal_type: study_or_research
allowed_category: "chronic disease management"
trend_strength_score: 68
opportunity_score: 70
discover_score: 4
urgency: this_week
confidence: medium
content_status: new
source_count: 1
recommended_angle: "Practical 'should I get this test' explainer answering who actually benefits from coronary calcium scoring vs. who it may not help — direct answer to a common patient question."
why_now: "New WaPo-reported study directly relevant to a widely-marketed preventive screening test; audience decision-relevant."
primary_headline: "Should You Get a Heart Calcium Scan? A New Study Says It Depends"
next_steps: "Verify underlying journal/DOI via WaPo article before drafting; note study population and design (observational vs. RCT)."
notes: "⚠️ Integrity note: single study — avoid blanket 'skip this test' framing; note who the finding does/doesn't apply to."
sources:
  - {publisher: "Washington Post", url: "https://www.washingtonpost.com/wellness/2026/08/28/calcium-testing-heart-health-may-have-limited-value-many-new-study-suggests/", tier: 1}
```

### P3 — Concise Briefs

```yaml
- headline: "Moderna Starts Phase 1 Trial for an Ebola Vaccine Aimed at the DRC Outbreak Strain"
  topic: "Moderna Ebola vaccine Phase 1 trial"
  angle: "Explain what Phase 1 actually tests (safety/dosing, not efficacy) and why a strain-specific vaccine matters for the current DRC outbreak."
  integrity_flags: ["⚠️ Phase 1 = safety only, not proof of efficacy — do not imply the vaccine works yet"]
  expert_type_needed: "Infectious disease epidemiologist"
  seo: {primary_keyword: "moderna ebola vaccine trial", format: "news explainer", serp_difficulty: "Medium"}
  sources: [{publisher: "ABC News", url: "https://abcnews.com/Health/moderna-begins-phase-1-clinical-trial-ebola-vaccine/story?id=135365177"}]
  estimated_word_count: "600-800"

- headline: "Inside the First US Clinical Trial of Ibogaine"
  topic: "Ibogaine clinical trial (Barrow/ASU)"
  angle: "Novel-treatment explainer covering ibogaine's addiction/PTSD research promise alongside its known cardiac risk profile and unapproved status."
  integrity_flags: ["⚠️ Ibogaine carries known cardiac risk and is not FDA-approved outside this trial — flag safety context prominently"]
  expert_type_needed: "Psychiatrist / addiction medicine specialist"
  seo: {primary_keyword: "ibogaine clinical trial", format: "explainer", serp_difficulty: "Easy"}
  sources: [{publisher: "ASU News", url: "https://news.asu.edu/20260831-health-and-medicine-barrow-asu-embark-one-first-clinical-trials-ibogaine-us"}]
  estimated_word_count: "600-800"

- headline: "Scientists Find Hidden Immune Cells in the Lungs That Could Lead to Better Flu Vaccines"
  topic: "Flu vaccine immune-cell discovery"
  angle: "Explain the basic-science finding in plain language and what 'could lead to better vaccines' realistically means on a research timeline."
  integrity_flags: []
  expert_type_needed: "Immunologist / infectious disease researcher"
  seo: {primary_keyword: "new flu vaccine research", format: "explainer", serp_difficulty: "Medium"}
  sources: [{publisher: "University of Rochester", url: "https://www.urmc.rochester.edu/news/story/hidden-immune-cells-in-the-lung-could-lead-to-better-flu-vaccines"}]
  estimated_word_count: "500-700"

- headline: "Food Insecurity Later in Life Linked to Higher Dementia Risk, Study Finds"
  topic: "Food insecurity & dementia risk"
  angle: "Evaluative piece distinguishing correlation from causation, with context on confounding factors (income, healthcare access) and practical takeaways."
  integrity_flags: ["⚠️ Association, not causation — food insecurity likely correlates with other dementia risk factors (income, healthcare access)"]
  expert_type_needed: "Geriatrician or epidemiologist"
  seo: {primary_keyword: "food insecurity dementia risk", format: "explainer", serp_difficulty: "Medium"}
  sources: [{publisher: "News-Medical", url: "https://www.news-medical.net/news/20260827/Study-links-later-life-food-insecurity-to-elevated-dementia-risk.aspx"}]
  estimated_word_count: "500-700"
```

---

## 7. Rejected Topics Log

| Topic | Reason |
|---|---|
| OpenAI–EHR integration, employer health cost spike (NYT), Corewell $1.7B investment, Sanford/North Memorial merger, UVA Lynchburg expansion, $50B rural health transparency | off_category — pure business/institutional expansion, no patient-health data angle |
| Sword Health–Headspace acquisition | off_category — pure M&A |
| Kroger wellness tours, CVS/LOVB partnership, BCG activewear-wellness report, campus/senior wellness events | brand_safety/off_category — marketing/PR, not evidence-based |
| Vanderbilt tribute to Dolly Parton | off_category — celebrity tribute, no health evidence |
| UW research funding cuts (Trump admin) | off_category — political healthcare policy framing |
| WHO World Mental Health Day webinar (Oct 9) | other — too far out, event announcement only |
| Florida DOH Miami-Dade water quality advisory | off_category — local, too narrow for national audience |
| Fresenius hemodiafiltration real-world evidence study | weak_signal — manufacturer-sponsored single-source study, conflict of interest |
| Penn proton therapy clinical trial launch | weak_signal — single institutional source, thin |
| Data4Life/Monash Dubai rWGS partnership | off_category — low audience relevance, international/niche |
| Clinical Leader "pharmacy benefit" industry commentary | off_category — trade commentary, not consumer-relevant |
| Low-carb/liver benefits study (WashU) | duplicate — covered 2026-08-27 |
| GLP-1 psychiatric safety study | duplicate — covered 2026-08-28 |
| Mental health awareness/suicide prevention month | duplicate — covered 2026-09-01, no new development |
| Medical marijuana & missing work (UGA study) | routed to **Monitor/P5** — below opportunity threshold (52<55), borderline category fit |

---

## 8. Integrity Flags — Consolidated

- ⚠️ **Food recall surge**: Don't imply a single systemic cause across unrelated recalls; separate confirmed recalls from active outbreak investigation.
- ⚠️ **Pancreatic cancer approval**: Approval ≠ cure — cite trial population/survival magnitude, avoid overpromising.
- ⚠️ **Calcium testing study**: Single study — avoid blanket "skip this test" advice; specify applicable population.
- ⚠️ **Moderna Ebola trial**: Phase 1 = safety/dosing only — do not imply proven efficacy.
- ⚠️ **Ibogaine trial**: Known cardiac risk profile, not FDA-approved outside trial — safety context must be prominent.
- ⚠️ **Food insecurity/dementia**: Association, not causation — confounders likely present.

---

## 9. Run Notes

- Google Trends confirmed available via injected pre-fetch; used as primary `search_velocity` input throughout.
- `site_url` not configured — self-check skipped; competitor-list fallback (`configs/competitor_list.yaml`) informed SERP-gap judgments.
- Recall stories, GLP-1 coverage, and mental-health-awareness-month content are recurring 3+ consecutive runs — flagged for staleness; suppressed today absent new development, per instructions.
- News-Medical sourcing for the food-insecurity/dementia item is secondary — writer must confirm the underlying journal/DOI before publishing (per Skill 02b note).
- Medical marijuana & workplace-absence topic held at Monitor (P5) — below both scoring thresholds; revisit only if a stronger primary/institutional source emerges.